Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7872367rdf:typepubmed:Citationlld:pubmed
pubmed-article:7872367lifeskim:mentionsumls-concept:C0022658lld:lifeskim
pubmed-article:7872367lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:7872367lifeskim:mentionsumls-concept:C0232804lld:lifeskim
pubmed-article:7872367lifeskim:mentionsumls-concept:C0011164lld:lifeskim
pubmed-article:7872367lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:7872367lifeskim:mentionsumls-concept:C0009924lld:lifeskim
pubmed-article:7872367lifeskim:mentionsumls-concept:C1880269lld:lifeskim
pubmed-article:7872367pubmed:issue1lld:pubmed
pubmed-article:7872367pubmed:dateCreated1995-3-30lld:pubmed
pubmed-article:7872367pubmed:abstractTextThe nephrotoxic potentials of a high-osmolar contrast medium, diatrizoate, and of a low-osmolar contrast medium, ioxaglate, were compared during early degenerative gentamicin-induced nephropathy in the rat. Male rats (13-22/group) were uninephrectomized. Six days later, the aorta was clamped above the renal artery, and either diatrizoate or ioxaglate was administered (1 ml/min for 3 min) via an aortic puncture into the remaining kidney. Some of the rats received chronic treatment with gentamicin (50 mg/kg/day i.m., 4 days), starting 2 days before and ending 1 day after contrast medium administration. Two control groups, only one of which received gentamicin, were subjected to a 3-min renal ischemia. The creatinine clearance (CrCl) per 100 g body weight was determined before and 24 and 48 h after contrast medium injection. A second study (6 rats/group) evaluated urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion and the histologic appearance of the kidneys (blinded analysis) in the same experimental groups. Gentamicin induced a significant decrease in CrCl at baseline (0.35 +/- 0.19 vs. 0.41 +/- 0.19 ml/min; p < 0.01) and an increase in urinary NAG (128 +/- 92 vs. 39 +/- 57 mumol/h/mmol creatinine; p < 0.01). Taking into account these differences at baseline, univariate repeated-measures analysis showed that on day 1 diatrizoate caused a more marked decrease in CrCl than ioxaglate (p < 0.05), whether or not gentamicin was also administered. On day 2, the depressant effect of diatrizoate associated with gentamicin persisted (CrCl vs. day 0 = -0.19 +/- 0.10 ml/min), while that of diatrizoate alone returned to baseline (-0.05 +/- 0.24 ml/min).(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:7872367pubmed:languageenglld:pubmed
pubmed-article:7872367pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7872367pubmed:citationSubsetIMlld:pubmed
pubmed-article:7872367pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7872367pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7872367pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7872367pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7872367pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7872367pubmed:statusMEDLINElld:pubmed
pubmed-article:7872367pubmed:issn0250-8095lld:pubmed
pubmed-article:7872367pubmed:authorpubmed-author:BourbouzeRRlld:pubmed
pubmed-article:7872367pubmed:authorpubmed-author:SantusRRlld:pubmed
pubmed-article:7872367pubmed:authorpubmed-author:BeaufilsHHlld:pubmed
pubmed-article:7872367pubmed:authorpubmed-author:BonnemainBBlld:pubmed
pubmed-article:7872367pubmed:authorpubmed-author:IdéeJ MJMlld:pubmed
pubmed-article:7872367pubmed:authorpubmed-author:JouanneauCClld:pubmed
pubmed-article:7872367pubmed:authorpubmed-author:BalutCClld:pubmed
pubmed-article:7872367pubmed:authorpubmed-author:HuntsmanA MAMlld:pubmed
pubmed-article:7872367pubmed:authorpubmed-author:KoeltzBBlld:pubmed
pubmed-article:7872367pubmed:issnTypePrintlld:pubmed
pubmed-article:7872367pubmed:volume15lld:pubmed
pubmed-article:7872367pubmed:ownerNLMlld:pubmed
pubmed-article:7872367pubmed:authorsCompleteYlld:pubmed
pubmed-article:7872367pubmed:pagination66-74lld:pubmed
pubmed-article:7872367pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:7872367pubmed:meshHeadingpubmed-meshheading:7872367-...lld:pubmed
pubmed-article:7872367pubmed:meshHeadingpubmed-meshheading:7872367-...lld:pubmed
pubmed-article:7872367pubmed:meshHeadingpubmed-meshheading:7872367-...lld:pubmed
pubmed-article:7872367pubmed:meshHeadingpubmed-meshheading:7872367-...lld:pubmed
pubmed-article:7872367pubmed:meshHeadingpubmed-meshheading:7872367-...lld:pubmed
pubmed-article:7872367pubmed:meshHeadingpubmed-meshheading:7872367-...lld:pubmed
pubmed-article:7872367pubmed:meshHeadingpubmed-meshheading:7872367-...lld:pubmed
pubmed-article:7872367pubmed:meshHeadingpubmed-meshheading:7872367-...lld:pubmed
pubmed-article:7872367pubmed:meshHeadingpubmed-meshheading:7872367-...lld:pubmed
pubmed-article:7872367pubmed:meshHeadingpubmed-meshheading:7872367-...lld:pubmed
pubmed-article:7872367pubmed:meshHeadingpubmed-meshheading:7872367-...lld:pubmed
pubmed-article:7872367pubmed:meshHeadingpubmed-meshheading:7872367-...lld:pubmed
pubmed-article:7872367pubmed:meshHeadingpubmed-meshheading:7872367-...lld:pubmed
pubmed-article:7872367pubmed:year1995lld:pubmed
pubmed-article:7872367pubmed:articleTitleComparative effects of low- and high-osmolar contrast media on the renal function during early degenerative gentamicin-induced nephropathy in rats.lld:pubmed
pubmed-article:7872367pubmed:affiliationLaboratoire Guerbet, Aulnay-sous-Bois, France.lld:pubmed
pubmed-article:7872367pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7872367pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7872367lld:pubmed